About NOVENANCE
Overview
Novenance is a retail forex and CFD broker that began operations in October 2025. Despite being registered in the United Kingdom, its official address is listed in Great Neck, New York, USA. The broker operates solely through its website novenance.us and currently holds no recognized financial regulatory licenses, a factor that places it in a high-risk category for traders.
Account Types and Minimum Deposits
Novenance offers a tiered account structure with seven distinct levels, catering to a range of deposit sizes. The entry-level Starter account requires a minimum deposit of $100, while the highest-tier Platinum account requires $40,000. Intermediate accounts include Basic ($500), Standard ($2,000), Premium ($5,000), Gold ($10,000), and Diamond ($20,000). However, no leverage information is provided for any of these accounts, leaving a key trading parameter unspecified.
Trading Instruments and Platform
The broker's website indicates that it offers trading on forex, cryptocurrencies, commodities, and indices via CFDs. It also mentions access to tools for planning trades, but no specific trading platform (e.g., MT4, MT5, proprietary) is named. The lack of clarity on execution methods and available instruments is a notable gap in public information.
Customer and Corporate Information
Novenance lists a corporate address at 11 Grace Avenue, Suite 108, Great Neck, New York, USA, despite its UK registration. The company appears to be newly established, with a foundation date of October 22, 2025. As of this writing, no independent user reviews are available, and aggregated industry data shows no record of regulatory approvals or client feedback.
Risk Assessment and Transparency
FXCanary's Scam Risk Score for Novenance is 57 out of 100, indicating an elevated risk profile. This score reflects the absence of regulatory oversight, a very short operational history, and limited publicly available information about the broker's ownership, execution practices, and dispute resolution mechanisms. Traders are advised to exercise caution.
Overview compiled by FXCanary from regulatory records and public data. full NOVENANCE review